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Abstract:  
Objective: To determine the efficacy of prochlorperazine, cyclizine and ondansetron in patients following 
laparoscopic cholecystectomy, in terms of prevention of vomiting and nausea. Study Type:  Randomized Control 
Trial. Duration and Location of Study: Anaesthesia department of the Bahawal Victoria Hospital, Bahawalpur 
over a period of January, 2018 to January, 2019. Methodology: Total of 324 patients divided into Group P, group 
O and group C received prochlorperazine (10mg), ondansetron (4mg) and cyclizine (50mg) respectively. Every 
patient was asked to tell when he/she is feeling nauseous, vomited and used additional antiemetic drugs. 
Descriptive data was compared by applying ANOVA test and Chi-square or Fischer’s exact test was applied on 
nominal data. Computer software SPSS version 23 was used to statistically analyze the data. P ≤0.05 was taken as 
significant., Results: Although occurrence of side effects was slightly higher in group-P, but all the groups were 
not statistically diffrent (p-value 0.581, 0.500 and 0.544 for headache, dizziness and sedation, respectively). 
Nausea and vomiting was observed in 4.6% in group-O patients, 5.5% in group-C patients and 8.3% in group-P 
patients, difference being statistically insignificant (p=0.500)., Conclusion: From the results of this study it can 
be concluded that all the three drugs i.e. cyclizine, ondansetron and prochlorperazine are equally effective and 
there is no statistically significant difference in terms of prevention of vomiting and nausea in patients undergoing 
cholecystectomy through laparoscope. 
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Introduction:   
Most common complaint is nausea and vomiting in patients within 24 to 48 hours following laparoscopic 
cholecystectomy and is called post-operative nausea and vomiting (PONV) 1. Frequency of vomiting and nausea 
after operation is 30% to 50%. Risk increased to 80% in the high risk patients. Brain, GI tract and vestibular system 
are involved in the pathophysiology of the nausea and vomiting following surgery 2. Nausea, retching and vomiting 
are the three steps of the process of nausea and vomiting. Nausea is the feeling of a need to vomit; while retching 
is the contraction of abdominal wall muscles, muscles of chest and diaphragm that occur with nausea, reflexive 
forceful removal of the upper gastrointestinal contents through the oral cavity is called vomiting 3. Feminine 
gender, smoking, past history of motion sickness and PONV are related with the higher risk of post-operative 
vomiting and nausea4. Incidence of PONV decreases with age in adult patients. Usage of volatile and inhalational 
anesthetics is connected with enhanced frequency of vomiting and nausea after operation. General anesthesia is 
associated with increased occurrence of PONV as compared to regional anesthesia 10. 
Incidence of PONV is also influenced by the type of surgical procedure. There is higher incidence in the head and 
neck, gynecological and in laparoscopic surgeries. Pneumoperitoneum is created during all the laparoscopic 
procedures which cause the increased frequency of PONV 5. We are studying the effects of PONV in patients who 
underwent laparoscopic cholecystectomy. There are many serious complications in the patients undergoing 
laparoscopic cholecystectomy of vomiting and nausea which ranges from rapture of skin suture, bleeding from 
surgical spot, dehydration and aspiration pneumonia which cause delay in healing and increase in the duration of 
hospital stay which in turn causes the increase risk of nosocomial infection 6. Any intervention which decreases 
the incidence of postoperative nausea and vomiting in patients would be beneficial and in this way complications 
of PONV can be avoided. 
Anti-emetics are the drugs which are used for the prevention of postoperative nausea and vomiting. They block 
neuroreceptors which are involved in the pathway of emesis. There are many types of antiemetic drugs which 
include antihistamines (H1 receptor antagonists), dopamine antagonists, serotonin receptor antagonists, NK1 
receptor antagonists, cannabinoids, benzodiazepines, anticholinergics and steroids 8. All classes of antiemetic 
drugs are associated with side effects like sedation, lethargy, skin sensitization, dry mouth, drowsiness, 
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constipation, hypotension, restlessness, diarrhea, anxiety, insomnia, headache, prolongation of QT interval, muscle 
pain 9. Ondansetron, cyclizine and prochlorperazine are the drugs which are used frequently in the avoidance of 
PONV in the patients who underwent laparoscopic cholecystectomy. Prochlorperazine is dopamine receptor 
antagonist, ondansetron is blocks the serotonin receptors and cyclizine blocks the histamine receptors. In our study 
we are going to compare the effectiveness of these drugs for preventing vomiting and nausea after operation in 
people undergoing laparoscopic cholecystectomy. 
 
Material n methods: 
A randomized control trail which was performed in Anaesthesia department of the Bahawal Victoria Hospital, 
Bahawalpur over a period of January, 2018 to January, 2019. Proper approval was obtained from hospital ethics 
committee. We obtained informed consent from all the patients before the start of the study. Study performed by 
Aamer M et al 11 was used as reference to calculate the sample size. Non probability consecutive sampling was 
our method to select the patients. Patients who were going under laparoscopic cholecystectomy with ASA status I 
or II without any male to female preference were included. Age of the patients in this study ranges from 20 to 40 
years. Patients with reflex esophagitis, pregnant females, peptic ulcer disease, antiemetic user, ASA status III and 
IV were excludes from the study. Patients who underwent emergency laparoscopic cholecystectomy and any drug 
allergy were also excluded from the study.  
Total of three hundred and twenty four patients were involved in this study. We divided the patients into three 
groups. Group P included the patients who received prochlorperazine after laparoscopic cholecystectomy. Group 
O contained the patients who received ondansetron and Group C patients received cyclizine after laparoscopic 
cholecystectomy. Each group contains 108 patients. Patients were admitted in the hospital one day prior to surgery 
and pre-anesthesia evaluation of each patient is done by a consultant anesthesiologist who was not aware of the 
current study. 
Before the induction of anesthesia none of the patient received any food or water for at least six hours. After that 
patients were shifted to the operation room where electrocardiography, pulse oximetry of every patient was done 
before, during and after the anesthesia induction. Blood pressure was monitored by non-invasive method during 
the whole process. Intravenous access was gained through a 16 gauge cannula. Fluids and electrolytes were 
replaced by using lactated ringer and gelofusine solution during the whole procedure of laparoscopic 
cholecystectomy. Mixture of midazolam, propofol and oxygen was used to induce anesthesia in every patient. 
Atracurium bromide was used for the relaxation of muscles and after achieving the relaxation laryngoscope blade 
was inserted into the mouth of every patient to achieve tracheal intubation by an appropriate sized endotracheal 
tube. 
The study drugs with which every patient is going to be injected were prepared by a nurse who did not know about 
this trail.  For the elimination of biasedness all the drugs were prepared in similar syringes. All the patients were 
given the drugs according to their groups. Group P received prochlorperazine (10mg), group O received 
ondansetron (4mg) and patients in the group C were given cyclizine (50mg). Isoflurane and Atracurium bromide 
were used for the maintenance of anesthesia if required. After completing the procedure of laparoscopic 
cholecystectomy neostigmine and glycopyrolate were given to every patient for the reversion of anesthesia. To 
clear the airway secretions are removed by applying gentle suction through the endotracheal tube. After clearing 
the secretions endotracheal tube was removed and patient is allowed to breathe on its own. 
To note the incidence of PONV within a day after surgery help was taken by consultant anesthetists who were not 
aware of the groups of the patients. Every patient was asked to tell when he/she is feeling nauseous and every time 
he/she vomited. Usage of additional antiemetic drugs which are not part of this study for the avoidance of 
postoperative nausea and vomiting was also taken into account. Metoclopramide was the drug which was given to 
the patients if postoperative nausea and vomiting was not controlled by the study drugs. Side effects like dizziness, 
headache and restlessness of the study drugs were also noted in all the patients. Descriptive data was compared by 
applying ANOVA test and Chi-square or Fischer’s exact test was applied on nominal data. Data was analyzed 
using SPSS v.23 and value of p ≤0.05 was considered statistically significant. Computer software SPSS version 
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In currents study, the difference in the age was not significant (P value 0.067), male to female ratio (p=0.697), 
ASA-I and ASA-II class patients (p=0.892), and body mass index (p=0.251). The duration of anesthesia and 
surgery was also not significantly different (p-value 0.550 and 0.526, respectively). (Table-I) 
Although occurrence of side effects was slightly higher in group-P, but the difference among all the groups was 
not statistically significant (p-value 0.581, 0.500 and 0.544 for headache, dizziness and sedation, respectively). 
Nausea and vomiting was observed in 4.6% in group-O patients, 5.5% in group-C patients and 8.3% in group-P 
patients but there was no statistically significant difference (P value 0.500). Emergency anti-emetic medication 
was required by 4.6% of the patients in group-O, 3.7% of the patients in group-C and 7.4% of the patients in group-
P (p=0.446). (Table-II) 
Table-I 
Baseline Characteristics 
Baseline Characteristics Group O n=108 Group C n=108 Group P n=108 P value 
Age (years) 36.42±4.72 36.70±4.60 35.33±4.32 0.067 
Male (n) 66 62 68 0.697 
ASA-I/ASA-II 94/14 96/12 94/14 0.892 
BMI (kg/m2) 24.35±3.63 24.31±3.99 25.06±3.53 0.251 
Anesthesia Duration (min) 109.31±17.59 111.87±17.72 110.42±16.48 0.550 
Surgery Duration (min) 104.75±14.70 105.83±14.50 103.60±14.17 0.526 
Data is presented as mean ± S.D or number; ASA=American society of anesthesiologists. 
Table-II 
Comparison of Side Effects 
Side Effects Group O n=108 Group C n=108 Group P n=108 P value 
Headache 8 (7.4) 7 (6.5) 11 (10.2) 0.581 
Dizziness 6 (5.5) 5 (4.6) 9 (8.3) 0.500 
Sedation 7 (6.5) 6 (5.5) 10 (9.3) 0.544 
Need for Rescue anti-emetics 5 (4.6) 4 (3.7) 8 (7.4) 0.446 
Data is presented as number (percentage) 
 
Discussion:   
In our study we deduced that the efficacy of all three drugs in controlling vomiting and nausea after operation is 
comparable and no significant difference occur in the effectiveness of these drugs. Side effects like headache, 
sedation and dizziness were observed more in group P patients as compared to group C and group O. Additional 
use of antiemetic drugs is less for the group C patients in comparison to group P and group O. 
Aamer M et al. 11 in their study conducted on 195 patients of laparoscopic cholecystectomy. They divide the 
patients into 3 groups and give them ondansetron, prochlorperazine and cyclizine according to their groups to 
control vomiting and nausea. On completing their study they said that these drugs are equally effective in the 
patients undergoing laparoscopic cholecystectomy to control vomiting and nausea which occur after operation. 
Grimsehl K et al. 12 did their study on seventy four patients of laparoscopic surgery and divide the patients into 
two groups. They give one group cyclizine and the other group ondansetron. They concluded that both the drugs 
are equally capable of preventing postoperative nausea and vomiting and there is no delay in discharge from 
hospital by using these drugs although they found that cyclizine is less expansive as compared to ondansetron. 
Singhal A et al. 13 did a review of different randomized trials to know the dissimilarity in the efficacy of the 5HT3 
antagonist (ondansetron) for inhibiting PONV as compared to all other drugs which are used to control vomiting 
and nausea after operation. They said that the 5HT3 antagonists are better in preventing postoperative nausea and 
vomiting as compared to other drugs. Peter S et al. 14 did the systemic review of the 41 trails and they compared 
the efficacy of drugs like cyclizine, prochlorperazine and metoclopramide with that of the ondansetron and 
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granisetron. They concluded that the 5HT3 antagonists are better for the prevention of the PONV. Catriona R 15 
comes to a conclusion that no group of antiemetic drug is better than the other in the prevention of postoperative 
nausea and vomiting. 
Khaterah I et al. 16 conducted a study on the sixty patients of laparoscopic cholecystectomy and divide the patients 
into two groups. One group received ondansetron and the other group received metoclopramide which is also a 
dopamine receptor antagonist and they found that efficacy of both drugs was comparable in terms of prevention 
of vomiting and nausea in patients undergoing laparoscopic cholecystectomy. In a study on the seventy eight 
patients undergoing hip or knee replacement it was concluded that the prochlorperazine is cheap drug as compared 
to ondansetron and there is less usage of additional antiemetic drugs with prochlorperazine. Trichak S et al. 18 
studied the eighty patients undergoing laparoscopic cholecystectomy and they noted that the efficacy of 
ondansetron is higher in preventing PONV as compared to dopamine receptor antagonist metoclopramide. 
Cholwill J et al. 7 conducted a double blind study to compare the effectiveness of cyclizine and ondansetron with 
that of placebo and they noticed that the incidence of PONV is very less in the patients who received ondansetron 
or cyclizine when compared with placebo and there is no difference in the efficacy of ondansetron and cyclizine.  
 
Conclusion 
From the results of this study it can be concluded that all the three drugs i.e. cyclizine, ondansetron and 
prochlorperazine are equally effective and there is no statistically significant difference in terms of prevention of 
vomiting and nausea in patients undergoing cholecystectomy through laparoscope. 
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